Stage III Sinonasal Cancer AJCC v8
4 clinical trials · Condition
◉ Watch Stage III Sinonasal Cancer AJCC v8
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091) | National Cancer Institute (NCI) | 2022-07-06 |
Track Stage III Sinonasal Cancer AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.